About Scopio Labs
Scopio Labs is a company based in Tel Aviv (Israel) founded in 2014. Scopio Labs has raised $125 million across 7 funding rounds from investors including OurCrowd, Mizrahi-Tefahot Bank and Kreos Capital. Scopio Labs offers products and services including Scopio X100, Scopio X100HT, and Peripheral Blood Smear Application. Scopio Labs operates in a competitive market with competitors including PathAI, Deepcell, Aignostics, Definiens and Akoya Biosciences, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$125 M (USD)
in 7 rounds
-
Latest Funding Round
$10 M (USD), Series D
Jul 25, 2025
-
Investors
OurCrowd
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scopio Labs
Scopio Labs offers a comprehensive portfolio of products and services, including Scopio X100, Scopio X100HT, and Peripheral Blood Smear Application.
Digital system for small labs to analyze blood smears at high resolution.
High-throughput platform for advanced bone marrow and blood diagnostics.
AI tool for evaluating blood cell morphology and differentials.
People of Scopio Labs
Unlock access to complete
Funding Insights of Scopio Labs
Scopio Labs has successfully raised a total of $125M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Scopio Labs
Scopio Labs has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include OurCrowd, Mizrahi-Tefahot Bank and Kreos Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Scopio Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scopio Labs
Investment portfolio details for Scopio Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scopio Labs
Detailed financials for Scopio Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scopio Labs Comparisons
Peer comparison for Scopio Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scopio Labs
Scopio Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Deepcell, Aignostics, Definiens and Akoya Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
|
|
| Locked | Locked | Locked |
Provider of solutions for rapid proteomic profiling
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of Scopio Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scopio Labs
Complete news archive for Scopio Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scopio Labs
Scopio Labs was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Scopio Labs is headquartered in Tel Aviv, Israel.
Scopio Labs is a funded company, having raised a total of $125M across 7 funding rounds to date.
Provider of computational imaging-based digital microscopes image analysis tools. The products of the company include Scopio X100 and Scopio X100HT for Peripheral Blood Smear and veterinary applications. Claims that its products enable clinical and research improvements in the areas such as cancer, hematology, and cytology as well as help in academic research and drug discovery.
Scopio Labs's top competitors include Aignostics, Pictor Labs and PathAI.
Scopio Labs offers Scopio X100, Scopio X100HT, and Peripheral Blood Smear Application.
Scopio Labs has 13 investors. Key investors include OurCrowd, Mizrahi-Tefahot Bank, Kreos Capital, European Union, and Ilex Medical.